ADVISORY AGREEMENTAdvisory Agreement • July 15th, 2015 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
DelMar Pharmaceuticals, Inc. (“DelMar” or the “Company”) is undertaking a registered offering of an aggregate of up to 13,333,333 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and up to 13,333,333 warrants (the “Warrants”), each Warrant entitles the holder to purchase one share of Common stock at an exercise price of $0.75 per Warrant at any time prior to five years from the issuance date (the “Warrant Shares”). The Shares, Warrants and Warrant Shares have been registered on a Registration Statement on Form S-1, as amended (Securities and Exchange Commission file number 333-203357). The Shares, the Warrants and the Warrant Shares are collectively referred to as the “Securities”.
